 |
|
|
|||||
Sun Pharma Advanced Research Company (SPARC) psoriasis drug, Vibozilimod (SCD-044), failed to meet primary endpoints in Phase 2 trials for psoriasis and atopic dermatitis. The company has decided to discontinue development of the drug. Separately, a surprise FDA inspection is underway at Sun Pharmas Halol manufacturing facility.
Category:
News and Media
Cochin Shipyard shares: The stock has posted exceptional gains, surging nearly 737% in the past two years, 1,178% over three years, and 1,649% in five years. Cochin Shipyard now holds a market capitalisation of Rs 55,272 crore.
Category:
News and Media
Coforge shares: The company set June 4, 2025, as the record date to identify shareholders entitled to receive the split equity shares. As part of the corporate action, each equity share with a face value of Rs 10 has been divided into five shares with a face value of Rs 2 each.
Category:
News and Media
Shares of Garden Reach Shipbuilders and Engineers (GRSE) surged 10% after signing an MoU with Norways Kongsberg for Indias first Polar Research Vessel. The deal marks a significant boost for GRSE amid its ongoing defence shipbuilding projects, including the Navys Next Generation Corvettes order.
Category:
News and Media
Market expert Sunil Subramaniam believes the US-India bilateral trade agreement (BTA) is the key international trigger for the market's next rally. While domestic mutual funds have provided support, a significant market surge depends on the return of foreign institutional investors (FIIs) following a successful BTA conclusion after July 9th.
Category:
News and Media
Sites : [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] next »